Summary

for people ages 6 months to 100 years (full criteria)
at La Jolla, California and other locations
study started

Description

Summary

The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.

Official Title

A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.

Keywords

Outcomes Survival Rates CMX001

Eligibility

You can join if…

Open to people ages 6 months to 100 years

  • Have previously completed study CMX001-301 through the Week 24 visit, or participated in another qualifying clinical study with CMX001.
  • Willing and able to understand and provide written informed consent to participate in this observational study
  • Willing and able to participate in all required study activities for the entire duration of the observational study (i.e., agreeable to being contacted at periodic intervals over the course of approximately 10 years following the completion of study CMX001-301 or other qualifying clinical study.

You CAN'T join if...

Locations

  • University of California San Diego accepting new patients
    La Jolla California 92093 United States
  • St. Vincent Medical Center accepting new patients
    Los Angeles California 90006 United States
  • Children's Hospital of LA accepting new patients
    Los Angeles California 90027 United States
  • UCLA Medical Center accepting new patients
    Los Angeles California 90095 United States

Details

Status
accepting new patients
Start Date
Sponsor
Chimerix
ID
NCT02167685
Study Type
Observational [Patient Registry]
Last Updated
July 2017